Practice Management News

As we approach the year end, many investors, including physicians, will review their portfolios and assess the last 12 months of performance.

SAN DIEGO — Maintaining immunosuppression with or without low-dose glucocorticoids is superior to withdrawing both therapies in preventing relapses in IgG4-related disease, according to data presented at ACR Convergence 2023.

Come the new year, a “mini” pill could have a massive impact in rheumatology care.

It's that time of year again, everyone rolling up their sleeves to get a flu shot. This episode dives into the history of the struggles pinning down the causative agent of flu and the journey to the vaccine!

During an introductory press briefing, new NIH Director Monica M. Bertagnolli, MD, FACS, FASCO, called for a greater focus in clinical research to improve access to care.

Historically in the United States, Medicare has not had the legal authority to negotiate the prices of drugs. Essentially, drug prices were unregulated.

SAN DIEGO — Janus kinase and interleukin-6 inhibitors are superior to other targeted agents as a first-line therapy for VEXAS syndrome, according to data presented at ACR Convergence 2023.

Experts weighed in on the best ways to treat mild to severe drug reaction with eosinophilia and systemic symptoms, according to a study.

As baby boomers age into their 70s and 80s, it is estimated that more than $84 trillion will pass down through inheritances to millennial and Gen X heirs before 2045.

In this episode of Meeting Mic, we bring you Healio’s top headlines from ACR Convergence 2023.